Proposal for classifying the acute emetogenicity of cancer chemotherapy.
作者： P J Hesketh , M G Kris , S M Grunberg , T Beck , J D Hainsworth
DOI: 10.1200/JCO.1997.15.1.103
关键词:
摘要: … of chemotherapy agents, … chemotherapy agents to one of five emetogenic levels by consensus. A preliminary algorithm to determine the emetogenicity of combination chemotherapy …
elsevier.com
sci-hub.se 参考文章(64)
PJ Walther, SD Williams, M Troner, FA Greco, R Birch, LH Einhorn, None, Phase II study of etoposide for carcinoma of the prostate. Cancer treatment reports. ,vol. 70, pp. 771- 772 ,(1986)
Douillard Jy, Besson F, Monnier A, Chomy P, Pujol Jl, Le Chevalier T, Riviere A, Lianes P, Cigolari S, Alberola, A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Seminars in Oncology. ,vol. 21, pp. 28- 34 ,(1994)
Benton M Wheeler, PJ Loehrer, SD Williams, LH Einhorn, None, Ifosfamide in refractory male germ cell tumors. Journal of Clinical Oncology. ,vol. 4, pp. 28- 34 ,(1986) , 10.1200/JCO.1986.4.1.28
E A Eisenhauer, W W ten Bokkel Huinink, K D Swenerton, L Gianni, J Myles, M E van der Burg, I Kerr, J B Vermorken, K Buser, N Colombo, European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. Journal of Clinical Oncology. ,vol. 12, pp. 2654- 2666 ,(1994) , 10.1200/JCO.1994.12.12.2654
P Eisenberg, M Kane, W A Bierman, J Mortimer, E Genevois, R E Bellet, P M Ravdin, H A Burris, G Cook, Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer. Journal of Clinical Oncology. ,vol. 13, pp. 2879- 2885 ,(1995) , 10.1200/JCO.1995.13.12.2879
Frank V Fossella, Jin Soo Lee, Dong M Shin, Maria Calayag, Martin Huber, Roman Perez-Soler, William K Murphy, Scott Lippman, Steven Benner, Bonnie Glisson, None, Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 13, pp. 645- 651 ,(1995) , 10.1200/JCO.1995.13.3.645
K K Jain, E S Casper, N L Geller, T B Hakes, R J Kaufman, V Currie, W Schwartz, C Cassidy, G R Petroni, C W Young, A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. Journal of Clinical Oncology. ,vol. 3, pp. 818- 826 ,(1985) , 10.1200/JCO.1985.3.6.818
A Saven, R H Lemon, M Kosty, E Beutler, L D Piro, 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia. Journal of Clinical Oncology. ,vol. 13, pp. 570- 574 ,(1995) , 10.1200/JCO.1995.13.3.570
C M Lindley, S Bernard, S M Fields, Incidence and duration of chemotherapy-induced nausea and vomiting in the outpatient oncology population. Journal of Clinical Oncology. ,vol. 7, pp. 1142- 1149 ,(1989) , 10.1200/JCO.1989.7.8.1142
L X Cubeddu, I S Hoffman, N T Fuenmayor, A L Finn, Antagonism of serotonin S3 receptors with ondansetron prevents nausea and emesis induced by cyclophosphamide-containing chemotherapy regimens. Journal of Clinical Oncology. ,vol. 8, pp. 1721- 1727 ,(1990) , 10.1200/JCO.1990.8.10.1721